JP4012528B2 - 月経データに基づく情報配信システム - Google Patents
月経データに基づく情報配信システム Download PDFInfo
- Publication number
- JP4012528B2 JP4012528B2 JP2004219225A JP2004219225A JP4012528B2 JP 4012528 B2 JP4012528 B2 JP 4012528B2 JP 2004219225 A JP2004219225 A JP 2004219225A JP 2004219225 A JP2004219225 A JP 2004219225A JP 4012528 B2 JP4012528 B2 JP 4012528B2
- Authority
- JP
- Japan
- Prior art keywords
- information
- phase
- menstrual
- day
- data
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000009826 distribution Methods 0.000 title claims description 39
- 230000005906 menstruation Effects 0.000 title description 7
- 230000027758 ovulation cycle Effects 0.000 claims description 93
- 230000002175 menstrual effect Effects 0.000 claims description 67
- 230000016087 ovulation Effects 0.000 claims description 45
- 230000003821 menstrual periods Effects 0.000 claims description 26
- 229940088597 hormone Drugs 0.000 description 24
- 239000005556 hormone Substances 0.000 description 24
- 230000000694 effects Effects 0.000 description 21
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 14
- 229940011871 estrogen Drugs 0.000 description 11
- 239000000262 estrogen Substances 0.000 description 11
- 230000000740 bleeding effect Effects 0.000 description 10
- 230000003340 mental effect Effects 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- 206010036618 Premenstrual syndrome Diseases 0.000 description 9
- 230000008569 process Effects 0.000 description 9
- 230000008859 change Effects 0.000 description 8
- 230000035935 pregnancy Effects 0.000 description 8
- 238000012545 processing Methods 0.000 description 7
- 239000000186 progesterone Substances 0.000 description 7
- 229960003387 progesterone Drugs 0.000 description 7
- 230000004936 stimulating effect Effects 0.000 description 7
- 238000010586 diagram Methods 0.000 description 6
- 230000002745 absorbent Effects 0.000 description 4
- 239000002250 absorbent Substances 0.000 description 4
- 238000004891 communication Methods 0.000 description 4
- 230000000624 ovulatory effect Effects 0.000 description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 4
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000002996 emotional effect Effects 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000009245 menopause Effects 0.000 description 3
- 230000006996 mental state Effects 0.000 description 3
- 210000001672 ovary Anatomy 0.000 description 3
- 210000004681 ovum Anatomy 0.000 description 3
- 239000003488 releasing hormone Substances 0.000 description 3
- 230000001850 reproductive effect Effects 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 208000000412 Avitaminosis Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 206010027940 Mood altered Diseases 0.000 description 2
- 206010047627 Vitamin deficiencies Diseases 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 238000000222 aromatherapy Methods 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 238000013479 data entry Methods 0.000 description 2
- 238000002716 delivery method Methods 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 210000004696 endometrium Anatomy 0.000 description 2
- 210000000416 exudates and transudate Anatomy 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000036651 mood Effects 0.000 description 2
- 230000007510 mood change Effects 0.000 description 2
- 230000000136 postovulatory effect Effects 0.000 description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
- 230000001020 rhythmical effect Effects 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 210000001215 vagina Anatomy 0.000 description 2
- 239000011726 vitamin B6 Substances 0.000 description 2
- 235000019158 vitamin B6 Nutrition 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- 235000003332 Ilex aquifolium Nutrition 0.000 description 1
- 235000002296 Ilex sandwicensis Nutrition 0.000 description 1
- 235000002294 Ilex volkensiana Nutrition 0.000 description 1
- 206010021639 Incontinence Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 206010056344 Menstrual discomfort Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 206010061291 Mineral deficiency Diseases 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000008450 motivation Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000037312 oily skin Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000002611 ovarian Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 210000003635 pituitary gland Anatomy 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 230000036301 sexual development Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 208000022925 sleep disturbance Diseases 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000026676 system process Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Images
Landscapes
- Management, Administration, Business Operations System, And Electronic Commerce (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Description
CL=MSF(n)−MSF(n−1) (1)
MSF(n+1)=FD(n)+CL (2)
月経前相PMF(n)についての初日で現在の周期CY(n)内のものは、次の数式により得られる:
PMF(n)=MSF(n+1)−7 (3)
排卵後相の初日POF(n)で現在の周期CY(n)の中のものは、次の数式により得られる:
POF(n)=PMF(n)−7 (4)
排卵相の初日OVF(n)で現在の周期CY(n)の中のものは、次の数式により得られる:
OVF(n)=POF(n)−2 (5)
排卵前相の初日PRF(n)で現在の周期CY(n)の中のものは、次の数式により得られる:
PRF(n)=MSF(n)+AM+1 (6)
それぞれの相の終日は次の相の初日の1日前として単純に得られる。その結果、現在の月経周期CY(n)内のすべての相についてのすべての日数と日付とが得られる。同じように将来の月経周期CY(n+1,2,…)内の相の将来の日数と日付とがえられ識別することができる。
Claims (4)
- 月経データに基づき個人向け情報を配信するための情報配信システムであって、
女性の月経周期内の相により分類された相分類情報と、年齢データを含むプロフィルデータを分類したプロフィル分類情報とを記憶する情報データベースと、
各ユーザの前記月経データに基づいて月経周期内の相を特定するための相特定手段と、
該相特定手段により特定された相を検索タームとして用いて、前記情報データベースに記憶された前記相分類情報及びプロフィル分類情報から個人向け情報を検索する検索手段と、
前記検索された個人向け情報を配信するための配信手段とを備え、
該配信手段は個人向け情報の配信のタイミングが前記相特定手段により特定された相に応答していることを特徴とする情報配信システム。 - 前記配信のタイミングは前記相特定手段により特定された相の開始前に配信することを特徴とする請求項1に記載の情報配信システム。
- 前記配信のタイミングは月経期間相の初日の1日前、月経期間相最終日、排卵相の初日、排卵相の最終日、月経期間前相の初日、及び/又は月経期間相の最終日に配信することを特徴とする請求項1に記載の情報配信システム。
- 前記配信のタイミングはユーザが1月経周期中の配信頻度及び/又は配信数を指定することができることを特徴とする請求項1に記載の情報配信システム。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004219225A JP4012528B2 (ja) | 2004-07-27 | 2004-07-27 | 月経データに基づく情報配信システム |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004219225A JP4012528B2 (ja) | 2004-07-27 | 2004-07-27 | 月経データに基づく情報配信システム |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2001541328A Division JP3977080B2 (ja) | 2000-08-10 | 2000-08-10 | 月経データに基づく勧告情報を検索する情報検索システム |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2004342129A JP2004342129A (ja) | 2004-12-02 |
JP4012528B2 true JP4012528B2 (ja) | 2007-11-21 |
Family
ID=33535938
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2004219225A Expired - Fee Related JP4012528B2 (ja) | 2004-07-27 | 2004-07-27 | 月経データに基づく情報配信システム |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4012528B2 (ja) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010148689A (ja) * | 2008-12-25 | 2010-07-08 | Toshiba Corp | 体温計、情報処理装置およびプログラム |
JP6608142B2 (ja) * | 2015-01-28 | 2019-11-20 | 株式会社野村総合研究所 | サーバ装置 |
CN105793877A (zh) * | 2015-10-31 | 2016-07-20 | 深圳还是威健康科技有限公司 | 一种生理期数据处理的方法、装置及终端 |
JP6833947B2 (ja) * | 2019-10-23 | 2021-02-24 | 株式会社野村総合研究所 | サーバ装置 |
JP2024112655A (ja) * | 2023-02-08 | 2024-08-21 | ユニ・チャーム株式会社 | 情報処理装置、情報処理方法、情報処理プログラム及び情報処理システム |
-
2004
- 2004-07-27 JP JP2004219225A patent/JP4012528B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP2004342129A (ja) | 2004-12-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8632474B2 (en) | System and method for providing information based on menstrual data | |
JP3977080B2 (ja) | 月経データに基づく勧告情報を検索する情報検索システム | |
Higgins et al. | The sexual acceptability of contraception: reviewing the literature and building a new concept | |
Thomas et al. | Nuisance or natural and healthy: should monthly menstruation be optional for women? | |
Hahn et al. | Correlates of menstrual cycle characteristics among nulliparous Danish women | |
Nagata et al. | Soy product intake and hot flashes in Japanese women: results from a community-based prospective study | |
JP6608142B2 (ja) | サーバ装置 | |
Herman-Giddens et al. | Secondary sexual characteristics in boys: estimates from the national health and nutrition examination survey III, 1988-1994 | |
Guthrie | Continuity in UK general practice: a multilevel model of patient, doctor and practice factors associated with patients seeing their usual doctor | |
Bunting et al. | Development and preliminary validation of the fertility status awareness tool: FertiSTAT | |
Izumi et al. | Impact of smoking habit on medical care use and its costs: a prospective observation of National Health Insurance beneficiaries in Japan | |
DeMaria et al. | Prevalence and correlates of pubic hair grooming among low-income Hispanic, Black, and White women | |
Radoš et al. | Limited role of body satisfaction and body image self-consciousness in sexual frequency and satisfaction in pregnant women | |
Ali et al. | Do fertility tracking applications offer women useful information about their fertile window? | |
Li et al. | Hot tub use during pregnancy and the risk of miscarriage | |
Wright et al. | A qualitative exploration of emergency contraception users' willingness to select the copper IUD | |
Kim et al. | The relationship between parity and overweight varies with household wealth and national development | |
Nanda et al. | Experiences with the levonorgestrel-releasing intrauterine system in Kenya: qualitative interviews with users and their partners | |
JP4012528B2 (ja) | 月経データに基づく情報配信システム | |
Morabia et al. | Recent reversal of trends in hormone therapy use in a European population | |
Gonçalves et al. | Frequency and experience in the use of menstrual cycle monitoring applications by Brazilian women | |
Paarlberg et al. | Request for operative reduction of the labia minora; a proposal for a practical guideline for gynecologists | |
JP4047838B2 (ja) | 情報検索システム | |
Wiegratz et al. | Prescribing preferences and personal experience of female gynaecologists in Germany and Austria regarding use of extended-cycle oral contraceptives | |
JP6788943B2 (ja) | サーバ装置 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20070810 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20070907 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100914 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110914 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120914 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120914 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130914 Year of fee payment: 6 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |